101 related articles for article (PubMed ID: 175643)
1. [Complement-dependent immune cytolysis of cells from transplantable myeloid tumor].
Iakimov M
Acta Microbiol Virol Immunol (Sofiia); 1975; 2():52-6. PubMed ID: 175643
[No Abstract] [Full Text] [Related]
2. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus.
Herberman RB
J Natl Cancer Inst; 1972 Jan; 48(1):265-71. PubMed ID: 4119883
[No Abstract] [Full Text] [Related]
3. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
4. "Spontaneous" neoplastic transformation in vitro: influence of endogenous murine leukemia virus and serum fractions.
Sanford KK; Handleman SL; Hartley JW; Jackson JL; Gantt RR
J Natl Cancer Inst; 1972 Oct; 49(4):1177-89. PubMed ID: 4343474
[No Abstract] [Full Text] [Related]
5. Problems with and approaches to specificity in the serologic measurement of histocompatibility and tumor-associated antigens on tumor cell surfaces.
Klein PA
Transplant Proc; 1980 Mar; 12(1):16-21. PubMed ID: 6154353
[No Abstract] [Full Text] [Related]
6. Xenogenization.
Klein G
Jpn J Cancer Res; 1995 May; 86(5):inside front cover. PubMed ID: 7790312
[No Abstract] [Full Text] [Related]
7. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
Weinhold KJ; Wheelock EF
Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
[TBL] [Abstract][Full Text] [Related]
8. Effect of cortisone on oncogenesis by murine sarcoma virus (Moloney).
Shachat DA; Fefer A; Moloney JB
Cancer Res; 1968 Mar; 28(3):517-20. PubMed ID: 4867925
[No Abstract] [Full Text] [Related]
9. Complement fixation in conventional and regressing virus-induced murine leukemia.
Rich MA; Karl S; Clymer R
J Immunol; 1971 Jun; 106(6):1488-92. PubMed ID: 4326129
[No Abstract] [Full Text] [Related]
10. Serological studies of tumor antigens in chemical- and virus-induced thymic lymphomas.
Doell RG; Mathieson BJ
Cancer Res; 1971 Sep; 31(9):1285-9. PubMed ID: 4329884
[No Abstract] [Full Text] [Related]
11. Studies on the FMR antigen.
Lilly F; Nathenson SG
Transplant Proc; 1969 Mar; 1(1):85-9. PubMed ID: 4332534
[No Abstract] [Full Text] [Related]
12. Preparation and properties of an antiplasma cell serum directed against a defined plasmacytoma cell population.
Proctor ML; Herscowitz HB
J Immunol; 1975 Dec; 115(6):1642-9. PubMed ID: 1184969
[TBL] [Abstract][Full Text] [Related]
13. Some immunologically based reactions that can cause the regression of large tumor masses.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():105-8. PubMed ID: 799755
[TBL] [Abstract][Full Text] [Related]
14. Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice.
Fujimoto S; Chen CH; Sabbadini E; Sehon AH
J Immunol; 1973 Oct; 111(4):1093-100. PubMed ID: 4728678
[No Abstract] [Full Text] [Related]
15. Tumor antigens. 3. Immunological studies of tissue and tumor antigens and serum protein production by transplantable murine tumors.
Phillips ME
Int Arch Allergy Appl Immunol; 1970; 38(3):282-90. PubMed ID: 4984527
[No Abstract] [Full Text] [Related]
16. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
Stackpole CW; Cremona P; Leonard C; Stremmel P
J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
[No Abstract] [Full Text] [Related]
17. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
[TBL] [Abstract][Full Text] [Related]
18. Data on the cytotoxicity of anti-tumour sera.
Elek G; Vekerdi L
Acta Microbiol Acad Sci Hung; 1966-1967; 13(4):267-76. PubMed ID: 4963381
[No Abstract] [Full Text] [Related]
19. Immunology of virus-induced tumours.
Sjögren HO
Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
[No Abstract] [Full Text] [Related]
20. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
Ruddle NH; Armstrong MY; Richards FF
J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
[No Abstract] [Full Text] [Related]
[Next] [New Search]